This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

METabolic EXplorer Valuation

Is METEXP undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of METEXP when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate METEXP's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate METEXP's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for METEXP?

Key metric: As METEXP is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for METEXP. This is calculated by dividing METEXP's market cap by their current earnings.
What is METEXP's PE Ratio?
PE Ratio	1x
Earnings	€84.12m
Market Cap	€87.29m

METEXP key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.4x
Enterprise Value/EBITDA	-6.8x
PEG Ratio	-0.02x

Price to Earnings Ratio vs Peers

How does METEXP's PE Ratio compare to its peers?

The above table shows the PE ratio for METEXP vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	15.5x
IOF Iofina	12.7x	n/a	UK£36.5m
TET Treatt	22.1x	15.3%	UK£250.2m
KRPZ Kropz	2.1x	n/a	UK£12.0m
VCT Victrex	25.1x	37.8%	UK£769.6m
METEXP METabolic EXplorer	1x	-47.4%	€87.3m

Price-To-Earnings vs Peers: METEXP is good value based on its Price-To-Earnings Ratio (1x) compared to the peer average (90x).

Price to Earnings Ratio vs Industry

How does METEXP's PE Ratio compare vs other companies in the European Chemicals Industry?

3 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	28.1%
METEXP METabolic EXplorer	1x	-47.4%	US$90.80m

3 Companies		Estimated Growth	Market Cap
Industry Avg.	n/a	28.1%
METEXP METabolic EXplorer	1x	-47.4%	US$90.80m

No more companies

Price-To-Earnings vs Industry: METEXP is good value based on its Price-To-Earnings Ratio (1x) compared to the European Chemicals industry average (12.4x).

Price to Earnings Ratio vs Fair Ratio

What is METEXP's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

METEXP PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	1x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate METEXP's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Elkem

NOK 11.6b

Engages in the provision of advanced material solutions worldwide.

0SFN

NOK 18.31

1.8%

3.6%

TFF Group

€663.4m

Manufactures and distributes barrels and wood products for the aging of wines and alcohols in France, rest of Europe, the United States, Asia, and internationally.

0IH4

€29.10

-7.6%

-30.4%

NV Bekaert

€1.7b

Provides steel wire transformation and coating technologies worldwide.

0OQJ

€32.50

2.8%

-23.4%